Masato Komoda
-
- Colorectal Cancer Treatments and Studies 12
- Cancer Treatment and Pharmacology 7
- Peptidase Inhibition and Analysis 5
-
- Gastric Cancer Management and Outcomes 10
-
- Neuroendocrine Tumor Research Advances 3
-
- Signaling Pathways in Disease 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
-
- Chemotherapy-induced cardiotoxicity and mitigation 3
Masato Komoda
29 papers receiving 402 citations
Peers
Comparison fields: 5 of 59
- Oncology 186
- Cancer Research 54
- Internal Medicine 13
- Hematology 36
- Aging 5
Countries citing papers authored by Masato Komoda
This map shows the geographic impact of Masato Komoda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masato Komoda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masato Komoda more than expected).
Fields of papers citing papers by Masato Komoda
This network shows the impact of papers produced by Masato Komoda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masato Komoda. The network helps show where Masato Komoda may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masato Komoda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 7 | |
| 2 | 2023 | 1 | |
| 3 | 2022 | 2 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 1 | |
| 6 | 2019 | 22 | |
| 7 | 2017 | 38 | |
| 8 | 2017 | 3 | |
| 9 | 2016 | 2 | |
| 10 | 2015 | 6 | |
| 11 | 2014 | 6 | |
| 12 | 2014 | 3 | |
| 13 | Analysis of adverse events of bevacizumab-containing systemic chemotherapy for metastatic colorectal cancer in Japan. | 2014 | 11 |
| 14 | 2012 | 0 | |
| 15 | 2011 | 36 | |
| 16 | 2003 | 97 | |
| 17 | 2001 | 53 | |
| 18 | 2000 | 7 | |
| 19 | 1999 | 10 | |
| 20 | 1999 | 31 |
About Masato Komoda
Masato Komoda is a scholar working on Oncology, Internal Medicine and Pulmonary and Respiratory Medicine, having authored 32 papers that have together received 408 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (10 papers), Cancer Treatment and Pharmacology (7 papers), Peptidase Inhibition and Analysis (5 papers), Neuroendocrine Tumor Research Advances (3 papers), Signaling Pathways in Disease (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Chemotherapy-induced cardiotoxicity and mitigation (3 papers). The work is most often cited by research in Oncology (186 citations), Cancer Research (54 citations) and Internal Medicine (13 citations). Masato Komoda has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yuichi Hashimoto, Yasuyuki Fujimoto, Koichi Akashi, Hitoshi Kusaba, Eishi Baba, Fuminori Kato, Hiroshi Ariyama, Shizuo Kadoya, Hiroki Kakuta and Hiroyasu Takahashi. Their work appears in journals such as Journal of Clinical Oncology, Genes & Development and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.